Brandon Chen work email
- Valid
- Valid
Brandon Chen personal email
- Valid
Brandon has a track record of success in developing innovative biotechnologies to address health and environmental issues. Over his tenure at Finless Foods, Brandon has overseen research, development, business partnership, regulatory submission, pilot facility construction, manufacturing facility planning, intellectual properties, team development, and leadership training. Before joining Finless, Brandon led R&D teams to discover anti-cancer drugs synthesized with cell-free technology at Snap Bio, develop novel therapeutic biologics using mammalian cells at CODA Genomics, and produce bio-based chemicals with fermentation using engineered microbes at Genomatica. With his effective leadership and management skills, Brandon has built high-performance teams to develop proprietary technologies and commercial applications in cellular agriculture, cancer cell biology, synthetic biology, and metabolic engineering.Brandon works with his colleagues with respect, trust, empathy, passion, and compassion. As a leader in the biotech industry and a member of the LGBTQ+ community, Brandon embraces diversity, equity, and inclusion. He believes diversity in the team’s thinking and experience is a driving force for innovation. Brandon completed his post-doctoral training in cell biology and bioinformatics at The Scripps Research Institute. He earned his Ph.D. in microbiology and molecular genetics from the College of Medicine and an M.B.A. from the Paul Merage School of Business at the University of California, Irvine.
-
Chief Technology OfficerFinless Foods Nov 2019 - PresentEmeryville, California, UsAt Finless Foods, Brandon has shepherded the team in successfully raising Series A and Series B financings, including developing a Techno-Economic Analysis (TEA) model to guide manufacturing facility planning, production expansion, and finance strategy. Under Brandon’s scientific leadership and strategic guidance, Finless developed proprietary process technology for producing Bluefin tuna cells, submitted a regulatory dossier, and achieved R&D milestones toward commercializing cell-cultured seafood. Brandon led the construction project of Finless’ first pilot facility, from lease negotiation and space design to the commission of the pilot facility. He created and oversaw Finless’ culture committee to enhance company culture, organization cohesion, and effective communication. He provided leadership training to empower scientist-turned-managers to build a high-performance team. Brandon is also responsible for contract negotiations, business partnerships, and technology licensing. -
Co-Founder, Head Of Research And Development, Drug DiscoverySnap Bio May 2017 - Oct 2019San Diego, California, UsBrandon managed a virtual drug discovery team and successfully demonstrated the anti-cancer properties of novel chemicals synthesized with a proprietary cell-free technology he co-invested at Geomatica. As Head of R&D, he managed drug development programs through contract research organizations (CROs) to conduct cell-based assays, synthetic lethality, ADME, toxicology, animal models, and PK/PD studies. He also worked with academic research laboratories to incorporate synthetic biology, medicinal chemistry, and molecular simulation to rapidly advance novel chemical entities (NCE) targeting cancers with no good drugs to address unmet medical needs. As a co-founder, he participated in fundraising, investor communications, strategic planning, business partnerships, strategic alliances, intellectual properties, and financial budgeting. -
Research And DevelopmentGenomatica 2010 - 2017San Diego, Ca, UsBrandon led R&D project teams that engineered microbes to improve the titer and yield of bio-based chemicals using synthetic biology, metabolic pathway engineering, enzyme evolution, and robotic automation. He led a team to implement a robotic automation platform for straining engineering with integrated high-content data collection that enables data analytics and mining. His work contributed to commercializing the GENO Bio-BDO precision fermentation process, which converts sugars to 1,4-butanediol (BDO) at an industrial scale. He also led the early development work of Geno’s plant-based nylon. Later, Brandon co-invented a proprietary cell-free technology and led a cross-functional matrix team that applied this technology to produce novel chemical entities (NCEs) based on natural product scaffolding for drug discovery. He helped incubate this technology and spin off Snap Bio from Genomatica. -
ConsultantChen Consulting 2006 - 2017Brandon advised startup companies in technology evaluation, market assessment, financial modeling, and strategy in synthetic biology, metabolic engineering, bioinformatics, precision medicine, Next-Gen DNA sequencing, and molecular diagnostics.
-
Research & Commercial DevelopmentCoda Genomics. Inc. 2006 - 2009Brandon led CODA Genomics’ therapeutic biologics efforts to develop anti-TNF alpha antibodies and alternative biologic scaffolds. He was the project leader of early drug discovery and cell-based assay development programs. He and his team pioneered a novel synthetic DNA library assembly technology for rapidly evolving antibody and therapeutic biologics. Brandon also acted as a scientific liaison and project manager for client engagement, technical due diligence, intellectual property evaluation, and new technology assessment.
-
Research ScientistThe Scripps Research Institute 2004 - 2006La Jolla, California, UsBrandon developed a mammalian muscle cell differentiation mode and discovered the potential disease targets of hereditary muscular dystrophy disorders linked to genetic mutations of nuclear membrane proteins. -
Second Lieutenant (Mandatory Service)Taiwan Army 1994 - 1996Brandon served as a Second Lieutenant in the Taiwanese Army, as well as a medical officer, operation counselor, and platoon leader.
-
Medical TechnologistKaohsiung Medical University 1988 - 1992Kaohsiung, TwBrandon specialized in human physiology, pathology, diagnostic biochemistry, and medical microbiology.
Brandon Chen Skills
Brandon Chen Education Details
-
University Of California, Irvine - The Paul Merage School Of BusinessHealthcare & Finance -
Uc IrvineMicrobiology And Molecular Genetics
-
National Yang Ming UniversityMicrobiology And Immunology
-
Kaohsiung Medical UniversityMedical Science And Technology
Frequently Asked Questions about Brandon Chen
What company does Brandon Chen work for?
Brandon Chen works for Finless Foods
What is Brandon Chen's role at the current company?
Brandon Chen's current role is Chief Technology Officer at Finless Foods.
What is Brandon Chen's email address?
Brandon Chen's email address is ih****@****ail.com
What schools did Brandon Chen attend?
Brandon Chen attended University Of California, Irvine - The Paul Merage School Of Business, Uc Irvine, National Yang Ming University, Kaohsiung Medical University.
What skills is Brandon Chen known for?
Brandon Chen has skills like Molecular Biology, Biotechnology, Biochemistry, Lifesciences, Life Sciences, Microbiology, Genomics, Assay Development, Protein Chemistry, Cell Biology, Cell Culture, Cell.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial